People's Justice

Case guide

Old Zantac or a newer drug: which did I take?

Old ranitidine and Zantac 360 are different drugs. FDA also approved a new ranitidine formula in 2025.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202614 sources

This may apply to you if

  • Preparation suggestions only; no cancer list, use-duration threshold or current firm acceptance rule is verified.
  • Describe the product, dates and diagnosis you want checked.
  • Ask a lawyer what evidence and court route apply to your own situation.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Robin L. Rosenberg · United States District Court, Southern District of Florida · District judge signing order 81

Finding: The February 2023 order distinguishes five designated cancers from other injuries and recalls prior federal expert-evidence rulings. Its scope does not decide every state claim.

Federal court: February 14, 2023 Zantac order 81 (opens in a new tab) · Feb 14, 2023 · Checked Oct 4, 2026

The evidence and its limits

Yonsei University College of Medicine, first-author affiliation · JAMA Network Open · 2023

Ranitidine Use and Incident Cancer in a Multinational Cohort

Design:
Cohort
Participants:
1,183,999 eligible people across eleven analytical databases: 909,168 new ranitidine users and 274,831 other H2-blocker users. Primary meta-analysis used four databases meeting stricter balance criteria.
Finding:
The primary and broader comparisons did not show a statistically significant overall cancer increase relative to other H2 blockers.
Main limitation
Prescription or dispensing data do not capture all actual or nonprescription use; individual impurity and dietary exposure were not measured. Follow-up may miss long-latency effects and rare or small differences. The paper reports distinct primary, broader and calibrated estimates; no pooled number is presented as one universal eleven-database result. No individual cause or universal safety finding.

Read the source: Ranitidine Use and Incident Cancer in a Multinational Cohort (opens in a new tab) · Checked Oct 4, 2026

The short answer

What matters more than the name on the box?
Check the active ingredient, maker and date of use. The same familiar brand word does not show that every product had the same medicine. [13]
Was the 2020 withdrawal only for a brand?
No. FDA asked makers to remove the older drug. This covered prescribed products and those sold without a prescription. [4]
Is Zantac 360 the older ranitidine formula?
The Zantac 360 label names famotidine. That is a different drug. Its label does not show what was in a bottle you bought years ago. [13]
What changed with the 2025 ranitidine approval?
FDA approved new tablets in November 2025 after changes and tests. Ask your clinician before a switch. Follow the actual product’s storage directions. [5]

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Old ranitidine and Zantac 360 are different drugs. FDA also approved a new ranitidine formula in 2025. Check what you took; a brand name alone does not decide a claim.

What matters more than the name on the box?

Check the active ingredient, maker and date of use. The same familiar brand word does not show that every product had the same medicine.

As a preparation step, keep photos or dispensing details you already have. The Zantac 360 label names famotidine. The old FDA withdrawal concerns ranitidine; these are not the same ingredient.

Was the 2020 withdrawal only for a brand?

No. FDA asked makers to remove the older drug. This covered prescribed products and those sold without a prescription.

That does not mean every maker’s legal position is identical. A dated product-safety action does not identify the manufacturer of a particular bottle or decide a person’s cancer claim.

Is Zantac 360 the older ranitidine formula?

The Zantac 360 label names famotidine. That is a different drug. Its label does not show what was in a bottle you bought years ago.

Ask a pharmacist to help interpret a record that is unclear. This page does not tell you to switch drugs or assume the ingredients from advertising. Use the actual label or dispensing record where available.

What changed with the 2025 ranitidine approval?

FDA approved new tablets in November 2025 after changes and tests. Ask your clinician before a switch. Follow the actual product’s storage directions.

The November 2025 approval concerns the new formula and its storage directions. It is not a ruling that every older formula was safe or that a past cancer was caused by it.

Do brand and generic court claims have the same rules?

Do not assume they do. The federal order distinguishes brand claims and other parties. A lawyer must examine the actual product and rulings.

The February 2023 court paper sets a process for defined cancer cases. It does not certify every generic route or a nationwide personal deadline. Give the lawyer the maker, ingredient and case papers for a check.

Can the cancer study identify which maker caused my illness?

No. The 2023 study compares groups of drug users. It does not show what caused your cancer or measure the impurity dose you took.

Its main and broader comparisons found no clear overall increase, with exposure and follow-up limits. A study of groups does not replace a check of your own medicine, health and claim.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  2. Southern District of New York: time limitsSouthern District of New York: time limits · court
  3. 45 CFR 164.524: access to health records45 CFR 164.524: access to health records · regulator
  4. FDA: April2020 ranitidine withdrawal requestFDA: April2020 ranitidine withdrawal request · regulator
  5. FDA: reformulated ranitidine approvalFDA: reformulated ranitidine approval · regulator
  6. You: original multinational ranitidine cancer cohortYou: original multinational ranitidine cancer cohort · study
  7. Wang: original Taiwan ranitidine cohortWang: original Taiwan ranitidine cohort · study
  8. Jones: April14,2026 Delaware Zantac orderJones: April14,2026 Delaware Zantac order · court
  9. Jones: January29,2026 Delaware time-limit rulingJones: January29,2026 Delaware time-limit ruling · court
  10. GSK announced agreements with 10 plaintiff firms representing ~80,000 claimants (93% of pending US state-court Zantac cases) to pay up to $2.2 billion in aggregate, with full implementation expected by end of H1 2025; GSK admitted no liability. GSK also agreed to pay $70 million to resolve the Valisure qui tam complaint. Verified from GSK's own press statement.us.gsk.com · Oct 9, 2024
  11. Sanofi agreed to pay more than $100 million to settle ~4,000 Zantac cancer suits in state courts outside Delaware — the first major resolution in the litigation, averaging more than $25,000 per claim per Bloomberg's reporting (republished by Insurance Journal, Apr 23, 2024; deal announced earlier that month). Sanofi denied liability; 70,000+ suits then remained, mostly in Delaware.insurancejournal.com · Apr 23, 2024 · study
  12. MDL 2924 (S.D. Fla., Judge Robin L. Rosenberg) omnibus Daubert order (Doc 6120, 341 pages): ALL defendants' Daubert motions on general causation GRANTED and defendants' summary judgment motion GRANTED — plaintiffs 'fail to produce admissible primary evidence of general causation' that ranitidine causes cancer, ending the federal MDL claims. Verified from the court order itself.gsk.com · Dec 6, 2022 · court
  13. DailyMed: Zantac 360 famotidine label
  14. Federal court: February 14, 2023 Zantac order 81

Checked against 11 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026